FDA Webview
X
about-us-banner

FDA Related News

Home / Articles / FDA Related News
Medical Devices

FDA Clears Dental Caries AI Detector

FDA clears a VideaHealth 510(k) for its Videa Caries Assist, an artificial intelligence-powered dental caries (cavity) detection algorithm.

Biologics

FDA Limits Use of Janssen Vaccine Due to Clot Risk

FDA limits the emergency use authorization of Janssens Covid-19 vaccine to certain individuals 18 years of age and older due to the risk of thrombosis...

Human Drugs

CDER Study Verifies Continuous Manufacturing Benefits

Eleven CDER staffers say a Center self-audit of continuous manufacturing regulatory submissions verifies the benefits the agency has seen in such tech...

Human Drugs

FDA Approves Enhertu for Some Additional Breast Cancers

FDA approves a new indication for Daiichi Sankyos Enhertu for some breast cancer patients.

Human Drugs

Switching Generic Levothyroxine Maintains Thyroid Function: Study

FDA-sponsored research demonstrates that patients who switch between generic levothyroxine products maintain the same level of thyroid function as pat...

Human Drugs

15 Observations in Qualgen FDA-483

FDA releases the FDA-483 with 15 observations issued following an inspection at the Edmond, OK-based Qualgen outsourcing facility.

Medical Devices

Correlating Device Inspections with Warning Letters

Attorney Bradley Thompson uses data analysis to determine medical device inspection observations that more frequently are associated with Warning Lett...

Federal Register

Anesthetic/Analgesic Drugs Panel Renewal

Federal Register notice: FDA announces its renewal of the Anesthetic and Analgesic Drug Products Advisory Committee for an additional two years beyond...

Federal Register

Guide on Circulating Tumor DNA Drug Development

Federal Register notice: FDA makes available a draft guidance entitled Use of Circulating Tumor DNA for Early-Stage Solid Tumor Drug Development.

Human Drugs

More Transparency in Advisory Committee Use Needed: Researchers

Harvard University researchers who looked at FDAs use of advisory committees for new drugs say reforms in the process would improve transparency and a...